Triclocarban enhances testosterone action: a new type of endocrine disruptor?

Many xenobiotics have been associated with endocrine effects in a wide range of biological systems. These associations are usually between small nonsteroid molecules and steroid receptor signaling systems. In this report, triclocarban (TCC; 3,4,4'-trichlorocarbanilide), a common ingredient in personal care products that is used as an antimicrobial agent was evaluated and found to represent a new category of endocrine-disrupting substance. A cell-based androgen receptor-mediated bioassay was used to demonstrate that TCC and other urea compounds with a similar structure, which have little or no endocrine activity when tested alone, act to enhance testosterone (T)-induced androgen receptor-mediated transcriptional activity in vitro. This amplification effect of TCC was also apparent in vivo when 0.25% TCC was added to the diet of castrated male rats that were supported by exogenous testosterone treatment for 10 d. All male sex accessory organs increased significantly in size after the T+TCC treatment, compared with T or TCC treatments alone. The data presented here suggest that the bioactivity of endogenous hormones may be amplified by exposure to commercial personal care products containing sufficient levels of TCC.

[1]  R Abagyan,et al.  Discovery of antiandrogen activity of nonsteroidal scaffolds of marketed drugs , 2007, Proceedings of the National Academy of Sciences.

[2]  L. Fusani,et al.  Altered reproductive success in rat pairs after environmental-like exposure to xenoestrogen , 2007, Proceedings of the Royal Society B: Biological Sciences.

[3]  B. Hammock,et al.  Antiandrogenic properties of parabens and other phenolic containing small molecules in personal care products. , 2007, Toxicology and applied pharmacology.

[4]  R. Newbold,et al.  Developmental exposure to endocrine disruptors and the obesity epidemic. , 2007, Reproductive toxicology.

[5]  E. Eugster,et al.  Current concepts in normal and abnormal puberty. , 2007, Current problems in pediatric and adolescent health care.

[6]  Stanley R Krystek,et al.  Pharmacological and x-ray structural characterization of a novel selective androgen receptor modulator: potent hyperanabolic stimulation of skeletal muscle with hypostimulation of prostate in rats. , 2007, Endocrinology.

[7]  A. Sapkota,et al.  Detection of triclocarban and two co-contaminating chlorocarbanilides in US aquatic environments using isotope dilution liquid chromatography tandem mass spectrometry. , 2007, Environmental research.

[8]  K. Kannan,et al.  Developmental programming: differential effects of prenatal exposure to bisphenol-A or methoxychlor on reproductive function. , 2006, Endocrinology.

[9]  W. Hanneman,et al.  DEHP, bis(2)-ethylhexyl phthalate, alters gene expression in human cells: possible correlation with initiation of fetal developmental abnormalities , 2006, Human & experimental toxicology.

[10]  G. Greendale,et al.  Circulating bioactive androgens in midlife women. , 2006, The Journal of clinical endocrinology and metabolism.

[11]  J. T. Sanderson,et al.  The steroid hormone biosynthesis pathway as a target for endocrine-disrupting chemicals. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[12]  Carlos Sonnenschein,et al.  Endocrine disruptors and reproductive health: The case of bisphenol-A , 2006, Molecular and Cellular Endocrinology.

[13]  G. B. Buck Louis,et al.  Environmental influences on female fecundity and fertility. , 2006, Seminars in reproductive medicine.

[14]  N. Chirgadze,et al.  A second binding site for hydroxytamoxifen within the coactivator-binding groove of estrogen receptor beta. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[15]  S. Fenton Endocrine-disrupting compounds and mammary gland development: early exposure and later life consequences. , 2006, Endocrinology.

[16]  N. Roeleveld,et al.  Pesticide exposure: the hormonal function of the female reproductive system disrupted? , 2006, Reproductive biology and endocrinology : RB&E.

[17]  C. Sonnenschein,et al.  Strengths and weaknesses of in vitro assays for estrogenic and androgenic activity. , 2006, Best practice & research. Clinical endocrinology & metabolism.

[18]  J. McLachlan,et al.  Endocrine disrupters and female reproductive health. , 2006, Best practice & research. Clinical endocrinology & metabolism.

[19]  L. Guillette Endocrine Disrupting Contaminants—Beyond the Dogma , 2005, Environmental health perspectives.

[20]  S. Fenton,et al.  Adverse effects of prenatal exposure to atrazine during a critical period of mammary gland growth. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.

[21]  D. McDonnell,et al.  Androgen receptor-cofactor interactions as targets for new drug discovery. , 2005, Trends in pharmacological sciences.

[22]  Duane D. Miller,et al.  A Selective Androgen Receptor Modulator for Hormonal Male Contraception , 2005, Journal of Pharmacology and Experimental Therapeutics.

[23]  G. Coetzee,et al.  The role of protein kinase A pathway and cAMP responsive element-binding protein in androgen receptor-mediated transcription at the prostate-specific antigen locus. , 2005, Journal of molecular endocrinology.

[24]  E. Lobenhofer,et al.  Short-chain fatty acids enhance nuclear receptor activity through mitogen-activated protein kinase activation and histone deacetylase inhibition. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[25]  A. Vinggaard,et al.  Interlaboratory comparison of four in vitro assays for assessing androgenic and antiandrogenic activity of environmental chemicals. , 2004, Environmental health perspectives.

[26]  J. Isaacs,et al.  Molecular characterization of the commonly used human androgen receptor expression vector, pSG5‐AR , 2004, The Prostate.

[27]  D Stewart Irvine,et al.  How strong is the evidence of a link between environmental chemicals and adverse effects on human reproductive health? , 2004, BMJ : British Medical Journal.

[28]  J. Overstreet,et al.  Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on chorionic gonadotropin secretion by human trophoblasts. , 2003, Reproductive toxicology.

[29]  Duane D. Miller,et al.  Key structural features of nonsteroidal ligands for binding and activation of the androgen receptor. , 2003, Molecular pharmacology.

[30]  J. Dumoulin,et al.  Decreased human semen quality and organochlorine compounds in blood. , 2002, Human reproduction.

[31]  M. Gershengorn,et al.  Synergistic activation of the androgen receptor by bombesin and low-dose androgen. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[32]  C. Heinlein,et al.  Androgen receptor (AR) coregulators: an overview. , 2002, Endocrine reviews.

[33]  J. Shabanowitz,et al.  Androgen Receptor Phosphorylation REGULATION AND IDENTIFICATION OF THE PHOSPHORYLATION SITES* , 2002 .

[34]  F. S. French,et al.  Androgen receptor stabilization in recurrent prostate cancer is associated with hypersensitivity to low androgen. , 2001, Cancer research.

[35]  C. Wheelock,et al.  Evaluation of fish models of soluble epoxide hydrolase inhibition. , 2000, Environmental health perspectives.

[36]  V. Hertzberg,et al.  Age at Menarche and Tanner Stage in Girls Exposed In Utero and Postnatally to Polybrominated Biphenyl , 2000, Epidemiology.

[37]  W J Moorman,et al.  Male adolescent exposure to endocrine‐disrupting pesticides: vinclozolin exposure in peripubertal rabbits , 2000, Andrologia.

[38]  N. Bruchovsky,et al.  Prostate cancer: molecular biology of early progression to androgen independence. , 1999, Endocrine-related cancer.

[39]  B D Hammock,et al.  Potent urea and carbamate inhibitors of soluble epoxide hydrolases. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[40]  K. Taskén,et al.  Specificity in the cAMP/PKA signaling pathway. differential expression, regulation, and subcellular localization of subunits of PKA. , 2000, Frontiers in bioscience : a journal and virtual library.

[41]  T. Ikonen,et al.  Stimulation of androgen-regulated transactivation by modulators of protein phosphorylation. , 1994, Endocrinology.

[42]  B. Lasley,et al.  Luminescence luteinizing hormone/choriogonadotropin (LH/CG) bioassay: measurement of serum bioactive LH/CG during early pregnancy in human and macaque. , 1993, Biology of reproduction.

[43]  A. Hsueh,et al.  Expression of human luteinizing hormone (LH) receptor: interaction with LH and chorionic gonadotropin from human but not equine, rat, and ovine species. , 1991, Molecular endocrinology.

[44]  K. Ebeling,et al.  [Epidemiology of breast cancer]. , 1988, Archiv fur Geschwulstforschung.

[45]  J. Norris,et al.  Mechanism of androgen-receptor augmentation. Analysis of receptor synthesis and degradation by the density-shift technique. , 1985, The Journal of biological chemistry.

[46]  G. A. Nolen,et al.  Reproduction and teratogenic studies of a 2:1 mixture of 3,4,4'-trichlorocarbanilide and 3-trifluoromethyl-4,4'-dichlorocarbanilide in rats and rabbits. , 1979, Toxicology and applied pharmacology.

[47]  R. Hiles Metabolism and toxicity of halogenated carbanilides: absorption, distribution and excretion of radioactivity from 3,4,4'-trichloro[14C]carbanilide (TCC) and 3-trifluoromethyl-4,4'-dichloro[14C]carbanilide (TFC) in rats. , 1977, Food and cosmetics toxicology.

[48]  H. Maibach,et al.  Percutaneous penetration and disposition of triclocarban in man: body showering. , 1975, Archives of environmental health.

[49]  E. Sutherland,et al.  On the relation of cyclic AMP to adrenergic receptors and sympathin. , 1971, Advances in cytopharmacology.

[50]  H I Maibach,et al.  Regional variation in percutaneous penetration in man. Pesticides. , 1971, Archives of environmental health.